Effect of flumazenil on diaphragm electrical activation during weaning from mechanical ventilation after acute respiratory distress syndrome

British Journal of Anaesthesia

Volumn 114, Issue 2, 2015, Pages 269-275

  Roze, H ^a,b,c   Germain, A ^a   Perrier, V ^a   Dewitte, A ^a,b   Joannes Boyau, O ^a   Fleureau, C ^a   Ouattara, A ^a,b,c  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Bordeaux Segalen University   (France)

Author keywords

electrical diaphragm activation; mechanical ventilation; sedation; tidal volume

Indexed keywords

FLUMAZENIL; MIDAZOLAM; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; HYPNOTIC SEDATIVE AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTERIAL GAS; ARTICLE; BREATHING PATTERN; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAPHRAGM; DIAPHRAGM ELECTRICAL ACTIVATION; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HEART RATE; HEART RHYTHM; HUMAN; MALE; NERVOUS SYSTEM PARAMETERS; NEUROVENTILATORY EFFICIENCY; OBSERVATIONAL STUDY; OXYGEN TENSION; PH; PHYSICIAN; POSITIVE END EXPIRATORY PRESSURE; PRESSURE SUPPORT VENTILATION; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS; SEDATION; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SYSTOLIC BLOOD PRESSURE; TIDAL VOLUME; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; DRUG EFFECTS; ELECTROPHYSIOLOGY; HEMODYNAMICS; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GAS ANALYSIS; DIAPHRAGM; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; FLUMAZENIL; GABA MODULATORS; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; TIDAL VOLUME; VENTILATOR WEANING;

EID: 84922552138     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu374     Document Type: Article

References (32)

1. Sinderby C, Navalesi P, Beck J, et al. Neural control of mechanical ventilation in respiratory failure. Nat Med 1999; 5: 1433-6
2. Sinderby CA, Beck JC, Lindström LH, Grassino AE. Enhancement of signal quality in esophageal recordings of diaphragm EMG. J Appl Physiol 1997; 82: 1370-7
3. Sinderby C, Spahija J, Beck J, et al. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1637-41
4. Passath C, Takala J, Tuchscherer D, Jakob SM, Sinderby C, Brander L. Physiologic response to changing positive end-expiratory pressure during neurally adjusted ventilatory assist in sedated, critically ill adults. Chest 2010; 138: 578-87
5. DresM, Schmidt M, Ferre A, Mayaux J, Similowski T, Demoule A. Diaphragm electromyographic activity as a predictor of weaning failure. Intensive Care Med 2012; 38: 2017-25
6. Liu L, Liu H, Yang Y, et al. Neuroventilatory efficiency and extubation readiness in critically ill patients. Crit Care 2012; 16: R143
7. RozéH, Repusseau B, Perrier V, et al. Neuro-ventilatory efficiency during weaning from mechanical ventilation using neurally adjusted ventilatory assist. Br J Anaesth 2013; 111: 955-60
8. RozéH, Lafrikh A, Perrier V, et al. Daily titration of neurally adjusted ventilatory assist using the diaphragm electrical activity. Intensive Care Med 2011; 37: 1087-94
9. GoldmanMD, Grassino A, MeadJ, Sears TA. Mechanics of thehuman diaphragm during voluntary contraction: dynamics. J Appl Physiol Respir Environ Exerc Physiol 1978; 44: 840-8
10. Molliex S, Dureuil B, Montravers P, Desmonts JM. Effects ofmidazolam on respiratorymuscles in humans. Anesth Analg 1993; 77: 592-7
11. Barwing J, Ambold M, Linden N, Quintel M, Moerer O. Evaluation of the catheter positioning for neurally adjusted ventilatory assist. Intensive Care Med 2009; 35: 1809-14
12. Morel DR, Forster A, Bachmann M, Suter PM. Effect of intravenous midazolam on breathing pattern and chest wall mechanics in human. J Appl Physiol Respir Environ Exerc Physiol 1984; 57: 1104-10
13. Wilkinson M, GrovestineD, Hamilton JT. Flunitrazepambinding sites in rat diaphragm. Receptors for direct neuromuscular effects of benzodiazepines? Can J Physiol Pharmacol 1982; 60: 1003-5
14. Driessen JJ, Vree TB, Booij LH, van der Pol FM, Crul JF. Effect of some benzodiazepines on peripheral neuromuscular function in the rat in-vitro hemidiaphragm preparation. J Pharm Pharmacol 1984; 36: 244-7
15. Fujii Y, Hoshi T, Uemura A, Toyooka H. Dose-response characteristics of midazolam for reducing diaphragmatic contractility. Anesth Analg 2001; 92: 1590-3
16. Montravers P, Dureuil B, Desmonts JM. Effects of i.v. midazolamon upper airway resistance. Br J Anaesth 1992; 68: 27-31
17. Yan S, Kayser B. Differential inspiratory muscle pressure contributions to breathing during dynamic hyperinflation. Am J Respir Crit Care Med 1997; 156: 497-503
18. Mora CT, Torjman M, White PF. Effects of diazepam and flumazenil on sedation and hypoxic ventilatory response. Anesth Analg 1989; 68: 473-8
19. GrossJB, Weller RS, ConardP. Flumazenilantagonismofmidazolaminduced ventilatory depression. Anesthesiology 1991; 75: 179-85
20. Alexander CM, Teller LE, Gross JB. Slow injection does not prevent midazolam-induced ventilatory depression. Anesth Analg 1992; 74: 260-4
21. Mora CT, Torjman M, White PF. Sedative and ventilatory effects of midazolam infusion: effect of flumazenil reversal. Can J Anaesth 1995; 42: 677-84
22. Shalansky SJ, Naumann TL, Englander FA. Effect of flumazenil on benzodiazepine-induced respiratory depression. Clin Pharm 1993; 12: 483-7
23. Morin-Surun MP, Boudinot E, Gacel G, Champagnat J, Roques BP, Denavit-SaubieM. Different effects ofmuand delta opiate agonists on respiration. Eur J Pharmacol 1984; 98: 235-40
24. Shook JE, Watkins WD, Camporesi EM. Differential roles of opioid receptors in respiration, respiratory disease, and opiateinduced respiratory depression. Am Rev Respir Dis 1990; 142: 895-909
25. Gross JB, Blouin RT, Zandsberg S, Conard PF, Häussler J. Effect of flumazenil on ventilatory drive during sedation with midazolam and alfentanil. Anesthesiology 1996; 85: 713-20
26. Richard JCM, Lyazidi A, Akoumianaki E, et al. Potentially harmful effects of inspiratory synchronization during pressure preset ventilation. Intensive Care Med 2013; 39: 2003-10
27. Brander L, Leong-Poi H, Beck J, et al. Titration and implementation of neurally adjusted ventilatory assist in critically ill patients. Chest 2009; 135: 695-703
28. Gross JB, Zebrowski ME, Carel WD, Gardner S, Smith TC. Time course of ventilatory depression after thiopental and midazolam in normal subjects and in patients with chronic obstructive pulmonary disease. Anesthesiology 1983; 58: 540-4
29. Vozoris NT, Fischer HD, Wang X, et al. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 2014; 44: 332-40
30. Aubier M, Murciano D, Fournier M, Milic-Emili J, Pariente R, Derenne JP. Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1980; 122: 191-9
31. Colombo D, Cammarota G, Bergamaschi V, De Lucia M, Corte FD, Navalesi P. Physiologic response to varying levels of pressuresupport and neurally adjusted ventilatory assist in patients with acute respiratory failure. Intensive Care Med 2008; 34: 2010-8
32. Piquilloud L, Vignaux L, Bialais E, et al. Neurally adjusted ventilatory assist improves patient-ventilator interaction. Intensive Care Med 2011; 37: 263-71